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MaBACKGROUND Radiation therapy (RT) results in myocardial changes consisting of diffuse fibrosis, which may result in
changes in diastolic function.
OBJECTIVES The aim of this study was to explore RT-associated changes in left ventricular (LV) diastolic function.
METHODS Sixty chemotherapy-naive patients with left-sided, early-stage breast cancer were studied with speckle
tracking echocardiography at 3 time points: prior to, immediately after, and 3 years after RT. Global and regional early
diastolic strain rate (SRe) were quantified, as were parameters of systolic function.
RESULTS Regional changes in SRe, particularly the apical and anteroseptal segments, were observed over time and
were more evident than global changes. The apical SRe declined from a median of 1.24 (interquartile range: 1.01 to 1.39)
s-1 at baseline to 1.02 (interquartile range: 0.79 to 1.15) s-1 at 3 years of follow-up (p < 0.001). This decline was asso-
ciated with the left ventricular maximal radiation dose (b ¼ 0.36, p ¼ 0.007). The global SRe was <1.00 s-1 (SRedep) in 11
(18.3%) patients at baseline, 21 (35%) patients (p ¼ 0.013) post-RT, and 17 (28.3%) patients (p ¼ 0.051) at 3 years.
SRedep post-RT was independently associated with baseline cardiac abnormalities (odds ratio: 0.26; 95% confidence
interval: 0.08 to 0.84; p ¼ 0.025); SRedep at 3 years of follow-up was associated with the baseline Charlson comorbidity
index (odds ratio: 2.36; 95% confidence interval: 1.17 to 4.77; p ¼ 0.017). Diastolic function abnormalities were evident
even in patients with preserved global longitudinal strain at 3 years.
CONCLUSIONS RT resulted in changes in the SRe in the apical and anteroseptal segments over 3 years of follow-up.
Changes in SRe apical segments were present even in patients with preserved systolic function and were independently
associated with RT dose and cardiovascular comorbidities. (J Am Coll Cardiol CardioOnc 2021;3:277–89) © 2021 The
Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
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ABBR EV I A T I ON S
AND ACRONYMS
DGLS15 = relative decline of
more than 15% in global
longitudinal strain
CI = confidence interval
DLVmax = maximal left
ventricular radiation dose
GLS = global longitudinal
strain
IQR = interquartile range
LAVI = left atrial volume
indexed to body surface area
LV = left ventricular
LVEF = left ventricular ejection
fraction
RT = radiotherapy
SR = strain rate
SRe = early diastolic strain rate
SReapex = apical early diastolic
strain rate
SRedep = global early diastolic
strain rate <1 s-1
SRs = systolic strain rate
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278R adiotherapy (RT) is used to reducecancer recurrence and improve out-comes in patients with breast cancer.
However, the effects of RT are not limited to
tumor, as RT may induce adverse effects in
healthy tissue. Cardiac adverse effects (e.g.,
coronary stenosis, valvular lesions, pericar-
dial constriction, rhythm and conduction ab-
normalities) increase long-term cardiac
morbidity by 2-fold and heart failure risk by
7-fold (1,2). RT-induced diffuse myocardial
fibrosis and thickening of the left ventricular
(LV) wall may also result in heart failure with
preserved ejection fraction (2).
Several groups have recently reported that
RT impairs LV systolic function, as detected
by strain echocardiography and cardiac
magnetic resonance (3–6). As RT is postu-
lated to result in myocardial fibrosis, and
fibrosis is associated with diastolic dysfunc-
tion, we hypothesized that demonstration of
early changes in diastolic function might
provide new insights in the pathogenesis of
RT-induced cardiac dysfunction (7). The aimof this prospective study was to explore the effects of
RT on novel echocardiography-derived measures of
LV global and regional early diastolic strain rates
(SRe), and to further understand the relevance of
these changes in the context of systolic function (8).
METHODS
PATIENT COHORT. Female patients with early-stage
left-sided breast cancer were included in this single-
center prospective study. The inclusion and exclu-
sion criteria have been described previously (9).
Briefly, eligible female patients with early-stage
breast cancer were prospectively recruited. Exclu-
sion criteria included second malignancy, severe
lung disease, symptomatic heart failure, recent
acute myocardial infarction (6 months), atrial
fibrillation, pacemaker, left bundle branch block,
severe psychiatric disorder, pregnancy or breast
feeding, or under 18 or over 80 years of age. At
baseline, the Charlson comorbidity index was
calculated (10) and the following cardiac conditions
were identified, which we postulated increased the
vulnerability to RT-induced functional changes: a
mildly dilated LV >54 mm in size in end-diastole,
LV mass indexed to body surface area >100 g/m2,
ratio of early mitral inflow velocity and pulsed tis-
sue Doppler early diastolic velocity >15, global
longitudinal strain (GLS) >–15% (indicative of worse
function), greater than mild valvular disease, andprevious heart surgery or invasive coronary inter-
vention. No patients were treated with chemo-
therapy due to the early stage of the disease.
Clinical events including all-cause mortality and
cardiovascular hospitalizations were collected over
the follow-up time. The study complied with the
Declaration of Helsinki, and the local ethical com-
mittee approved the protocol. All participants
signed an informed consent form before enrollment.
RADIOTHERAPY. All patients received adjuvant
conformal RT after breast cancer surgery between
July 2011 and June 2013. A 3-dimensional treatment
planning computed tomography with 3-mm slices
was performed in a supine position in all patients.
Optimal fields and shields were used to spare the
heart from radiation as much as possible (Figure 1). RT
was administered according to normal institutional
clinical guidelines for a total of 50 Gy with 2-Gy
fractions or for a total 42.56 Gy with 2.66-Gy frac-
tions 5 days a week. Treatment contouring and
planning were done with Eclipse v.10 system (Varian
Medical Systems, Palo Alto, California). Dose volume
histograms, including cardiac structures, were
generated for each patient.
CARDIAC EXAMINATIONS. Patients were examined
prior to RT (0 to 69 days), after the end of RT (0 to
8 days), and 3 years after RT (2.8 to 3.2 years). All
echocardiography examinations were performed by
the same cardiologist (S.S.T.) using a Philips iE33 ul-
trasound machine (Philips Healthcare, Bothell,
Washington) and with a 1- to 5-MHz matrix-array X5-1
transducer according to a predefined protocol
including apical 4-, 3-, and 2-chamber views opti-
mized for strain analysis. All offline analyses were
performed using Philips QLAB 10.1 by a single cardi-
ologist blinded to cardiac RT dose. The SR curves for
each individual segment were manually analyzed
(Figure 2). In addition, a comprehensive evaluation of
diastolic parameters was performed, with grading of
diastolic function as per societal recommendations
(11). Reproducibility for global, regional (4 horizontal
regions including basal, mid, apical, and apex and 6
longitudinal regions including anterior, anteroseptal,
inferoseptal, inferior, inferolateral, and anterolateral
regions) and segmental (6 basal segments, 6 mid
segments, 6 apical segments, each divided into
anterior, anteroseptal, inferoseptal, inferior, infero-
lateral, and anterolateral segments, and 3 apex seg-
ments derived from 3 apical views) levels for SRe
were analyzed in 20 healthy volunteers, the repro-
ducibility values for systolic strain rates (SRs) have
been reported previously (9). GLS was also measured
to gain insight into systolic function. A relative
FIGURE 1 Radiotherapy Fields in 3-Dimensional Computed Tomography Treatment Planning
The treatment volume covered the remaining breast tissue after resection or left chest wall after mastectomy. Typically, the apical and
anteroseptal parts of the heart were in the radiotherapy field, here as yellow-orange fields in 2-dimensional (A) axial, (B) coronal, and (C)
sagittal images. (D) A 3-dimensional illustration is seen from the posterolateral view with apex and anterior parts of the heart imbedded in the
colored radiotherapy field.
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279decline in GLS of 15% (DGLS15) at 3 years was defined
as a clinically significant change as per guidelines (1).
FRAMERATE AND REPRODUCIBILITY ANALYSIS. All
imaging was actively optimized for strain analysis,
and the median frame rate was 69 (interquartile range
[IQR]: 61 to 78) frames/s. The SRe intraclass correla-
tion coefficient values with 95% confidence intervals
(CIs) for intraobserver variability were 0.810 (95% CI:
0.520 to 0.925) for global values, 0.883 (95% CI: 0.864
to 0.912) for regional values, and 0.792 (95% CI: 0.747
to 0.828) for segmental values. The values for
respective inter- and test-retest evaluations are
shown in Supplemental Table 1.
STATISTICAL ANALYSIS. Data are presented as
mean  SD for variables with normal distributions,as median (IQR) for non-normally distributed vari-
ables, or as numbers with percentages for categori-
cal variables. The differences between groups were
tested with independent-sample t tests, Mann-
Whitney U tests, and chi-square or Fisher’s tests,
as appropriate. To test the within group measure-
ment changes over time, mixed-effects models were
used. Patient was treated as a random factor and
time as fixed. First-order autoregressive covariance
structure was used to evaluate the repeated mea-
sures over time. Correlations were estimated using
Pearson correlation coefficients. Multivariable linear
regression analysis including age, use of aromatase
inhibitors, current smoking status, maximal LV dose
(DLVmax), Charlson comorbidity index, and subclin-
ical or stable cardiac conditions was performed with
FIGURE 2 Measurement of Early Diastolic Strain Rate
The apical 2-chamber view is presented on the top of the image with coloring over the myocardial segments. A cluster of strain rate curves is
displayed in the middle of the image. Aortic valve closure (AVC) is marked with an open white arrow. The low point prior AVC is the systolic
strain rate (s0) and the first high point after AVC is the early diastolic strain rate (e0). The lowest part of the image displays 1 individual segment
(apical anterior [APA] segment). The white arrow indicates the exact measurement of the segmental early diastolic strain rate of the APA.
API ¼ apical inferior; BA ¼ basal anterior; BI ¼ basal inferior; MA ¼ mid anterior; MI ¼ mid inferior.
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280a forward stepwise method with SRe and SRs
changes as the dependent variable; a binary logistic
regression model was used with depressed SRe
value at the 3-year follow-up time point as thedependent variable. For the reproducibility analysis,
the intraclass correlation with 2-way random testing
was used. The analysis was performed with IBM
SPSS version 25 (IBM, Armonk, New York). Two-
TABLE 1 Baseline Characteristics of the Study Population (N¼ 60)
Age, yrs 64 (49–83)





High cholesterol 14 (23.3)
None 28 (53.3)
Subclinical and clinical CV disease 17 (28.3)
LVEDD >54 mm 2 (3.3)
GLS >–15% 7 (11.7)
E/e0 >15 3 (5.0)
LVMi >100 g/m2 11 (18.3)
Greater than mild valvular abnormality 3 (5.0)
Prior heart surgery 1 (1.7)
Prior PCI 1 (1.7)













Mean LV dose 4.4 (0.8–12.3)
Max LV dose 45.8 (4.5–63.8)




Values are median (range) or n (%).
AI ¼ aromatase inhibitor; BMI ¼ body mass index; CV ¼ cardiovascular;
E/e0 ¼ ratio of early mitral inflow velocity and pulsed tissue Doppler early diastolic
velocity; GLS ¼ global longitudinal strain; LV ¼ left ventricular; LVEDD ¼ left
ventricular end-diastolic diameter; LVMi ¼ left ventricular mass indexed to the
body surface area; PCI ¼ percutaneous coronary intervention.
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281sided p values <0.05 were considered statisti-
cally significant.
RESULTS
PATIENT CHARACTERISTICS. All 60 patients
completed 3 years of follow-up. Seven (11.7%) pa-
tients were treated for a new or pre-existing cardiac
disorder during the follow-up period. Two (3.3%)
patients were treated for worsening of pre-existing
heart condition (1 for acute coronary syndrome and
1 for aortic stenosis). One (1.7%) patient received a
pacemaker for newly diagnosed sinus node dysfunc-
tion, 1 (1.7%) patient underwent catheter ablation forsupraventricular tachycardia, and 3 (5%) patients
were diagnosed with paroxysmal atrial fibrillation.
The characteristics of the population are shown
in Table 1.
GLOBAL SRs VALUES. Seven patients did not have
quantitation of strain at the baseline due to missing
data. Global SRs did not change significantly during
follow-up (Table 2). Patients with DGLS15 at 3 years of
follow-up (n ¼ 16) had a SRs worsening to a median of
0.23 (IQR: 0.05 to 0.42) s-1 versus an increase by 0.04
(IQR: –0.10 to 0.13) s-1 in patients without DGLS15
(n ¼ 39) (p ¼ 0.001). In multivariable analysis,
changes in global SRs during the 3-year follow-up
were not associated with use of aromatase in-
hibitors, current smoking status, DLVmax, Charlson
comorbidity index, or subclinical or stable car-
diac conditions.
GLOBAL SRe VALUES. Global SRe declined from
median 1.14 (IQR: 1.06 to 1.33) s-1 at baseline to 1.06
(IQR: 0.90 to 1.30) s-1 after RT (p ¼ 0.084), and to 1.10
(IQR: 0.87 to 1.27) s-1 at 3 years (p ¼ 0.069). SRe
was <1.00 s-1 (SRedep) in 11 (18.3%) patients at base-
line, in 21 (35.0%) patients post-RT (p ¼ 0.013), and in
17 (28.3%) patients at 3 years (p ¼ 0.051). In multi-
variable analysis, SRedep was not associated with any
baseline covariates. Immediately after RT, SRedep was
associated with baseline subclinical cardiac abnor-
malities (odds ratio: 0.26; 95% CI: 0.08 to 0.84;
p ¼ 0.025). At 3 years, the baseline Charlson comor-
bidity index was associated with SRedep (odds ratio:
2.36; 95% CI: 1.17 to 4.77; p ¼ 0.017). The global SRe at
3 years was 1.01 (IQR: 0.87 to 1.32) and 1.10 (IQR: 0.88
to 1.27) among patients with and without a cardiac
event during the follow-up, respectively, which was
not significantly different (p ¼ 0.658). SRedep was not
more prevalent among those who experienced a car-
diac event at 3 years (p ¼ 0.407).
REGIONAL SRs VALUES. Regional basal SRs values
are illustrated in Table 2. In patients with DGLS15, the
SRs apex worsened by 0.38 (IQR: 0.17 to 0.53) s-1,
while in patients without DGLS15, SRs apex changed
by only 0.01 (IQR: –0.15 to 0.10) s-1 (p < 0.001). In
multivariable analysis, the Charlson comorbidity in-
dex was independently associated with the change in
SRs apex at the 3-year follow-up time point (b ¼ –0.17;
95% CI: –0.33 to –0.01; p ¼ 0.044).
REGIONAL SRe VALUES. The regional SRe changes
are shown in Table 2 and in the Central Illustration.
The apex SRe (SReapex) had the greatest overall
decline throughout the follow-up period; this was by
–0.18 (IQR: –0.48 to 0.04) s-1. In multivariable anal-
ysis, the DLVmax was independently associated with D
SReapex (b ¼ 0.01, (95% CI: 0.00 to 0.02; p ¼ 0.007).
TABLE 2 Global and Regional Strain Rates
Baseline (n ¼ 53) After RT (n ¼ 58) 3-Year Follow-Up (n ¼ 60) p Value
Systolic
Global –1.25 (–1.45 to –1.11) –1.30 (–1.45 to –1.11) –1.27 (–1.40 to –1.14) 0.639
Basal –1.46 (–1.75 to –1.17) –1.62 (–1.87 to –1.37)* –1.58 (–1.85 to –1.33) 0.057
Mid –1.26 (–1.64 to –1.09) –1.38 (–1.60 to –1.09) –1.34 (–1.59 to –1.10) 0.396
Apical –1.09 (–1.29 to –0.95) –1.07 (–1.24 to –0.92) –1.04 (–1.16 to –0.90)†‡ 0.013
Apex –1.05 (–1.22 to –0.90) –0.99 (–1.15 to –0.87) –0.98 (–1.08 to –0.86)†‡ 0.026
Anterior –1.15 (–1.52 to –0.99) –1.20 (–1.59 to –1.00) –1.23 (–1.36 to –1.07) 0.349
Anteroseptal –1.25 (–1.55 to –1.07) –1.23 (–1.46 to –1.09) –1.22 (–1.42 to –1.09) 0.888
Inferoseptal –1.19 (–1.31 to –1.07) –1.21 (–1.40 to –1.10) –1.21 (–1.35 to –1.07) 0.514
Inferior –1.31 (–1.54 to –1.14) –1.39 (–1.72 to –1.16) –1.23 (–1.43 to –1.06)‡ 0.086
Inferolateral –1.31 (–1.85 to –1.06) –1.37 (–1.61 to –1.19) –1.53 (–1.71 to –1.82) 0.252
Anterolateral –1.31 (–1.80 to –1.07) –1.32 (–1.59 to –1.12) –1.36 (–1.67 to –1.15) 0.406
Early diastolic
Global 1.14 (1.06 to 1.33) 1.06 (0.90 to 1.30) 1.10 (0.87 to 1.27) 0.053
Basal 1.06 (0.87 to 1.18) 1.06 (0.86 to 1.35) 0.99 (0.83 to 1.32) 0.417
Mid 1.14 (1.00 to 1.53) 1.14 (0.90 to 1.48) 1.21(0.85 to 1.41) 0.569
Apical 1.25 (1.04 to 1.43) 1.08 (0.95 to 1.33) 1.05 (0.86 to 1.18) 0.438
Apex 1.24 (1.01 to 1.39) 0.76 (0.62 to 0.99)† 1.02 (0.79 to 1.15)†§ <0.001
Anterior 1.21 (0.95 to 1.50) 1.16 (0.86 to 1.53) 1.19 (0.94 to 1.40) 0.714
Anteroseptal 1.22 (0.93 to 1.44) 1.07 (0.84 to 1.45) 0.98 (0.75 to 1.21)†§ 0.008
Inferoseptal 1.21 (0.94 to 1.39) 1.12 (0.94 to 1.37) 1.11 (0.89 to 1.25) 0.170
Inferior 1.07 (0.79 to 1.40) 1.09 (0.85 to 1.38) 1.13 (0.81 to 1.38) 0.374
Inferolateral 1.17 (0.89 to 1.41) 1.18 (0.79 to 1.31) 1.13 (0.76 to 1.41) 0.368
Anterolateral 1.22 (0.90 to 1.44) 1.13 (0.89 to 1.41) 1.12 (0.85 to 1.34) 0.424
Values are median (interquartile range). Owing to missing primary data, strain analysis could not be performed in 7 patients at the baseline and in 2 patients after radiotherapy
(RT). The p values were derived from mixed model analysis with values <0.05. *p < 0.05 compared with baseline radiotherapy value. †p < 0.01 compared with baseline
radiotherapy value. ‡p < 0.05 compared with after radiotherapy value. §p < 0.01 compared with after radiotherapy value.
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282Each 1 Gy of DLVmax was associated with a D SReapex
of –0.012 s-1. The associations between D SReapex and
various heart radiation dose-volume metrics are
shown in Figure 3. The decline in SReapex was 0.18
(95% CI: 0.07 to 0.29) s-1 in patients without a clinical
event and 0.25 (95% CI: –0.10 to 0.60) with a clinical
event during the 3-year follow-up (p ¼ 0.655).
SEGMENTAL SR VALUES. The segmental systolic
(SRs) and diastolic (SRe) values are shown in Table 3.
The changes in both were concentrated in the apical
and anteroseptal regions.
CONVENTIONAL ECHOCARDIOGRAPHY MEASURES.The
results of conventional echocardiography are dis-
played in Table 4, and some of these results have
been previously published (9). A worsening in GLS
appeared early (p ¼ 0.003) and persisted throughout
the 3-year follow-up period (p ¼ 0.001). There was an
overall worsening of 1.7  3.5%. A late reduction in
the LV ejection fraction (LVEF) (p < 0.001), late in-
creases in the tricuspid regurgitation gradient
(p ¼ 0.016), and left atrial volume indexed to body
surface area (LAVI) (p ¼ 0.003) were observed at 3
years. LVEF declined by 5.2  9.8% from baseline to 3years, the tricuspid gradient increased by 2.0 
5.4 mm Hg, and the LAVI increased by 2.1  6.9 ml.
The changes of individual diastolic parameters for
the entire cohort are presented in Table 4. Patients
were graded as normal, grade 1 (abnormal relaxation),
grade 2 (pseudonormal filling), or grade 3 (restrictive
filling) diastolic dysfunction. The results of diastolic
grading are presented in Supplemental Figure 1.
Forty-three (71.6%) patients had no change in dia-
stolic grade, while 14 (23.3%) patients displayed
worsening and 3 (5.0%) patients had improved dia-
stolic grade at 3 years compared with baseline.
CHANGES IN DIASTOLIC FUNCTION MEASURES
ACCORDING TO CHANGES IN GLS. The diastolic
function parameters categorized according to DGLS15
are presented in Table 5. Patients with DGLS15 at 3
years (n ¼ 16) had greater changes in diastolic param-
eters over the same time period compared with pa-
tients without a significant change in GLS at 3 years
(n¼ 37). In patients with a DGLS15 at 3 years, the global
SRe declined by amedian of 0.25 (IQR: 0.05 to 0.47) s-1.
In contrast, in patients without a DGLS15, the global
SRe only declined by 0.05 (IQR: –0.13 to 0.18) s-1
CENTRAL ILLUSTRATION Radiotherapy-Associated
Changes in Left Ventricular Strain Rate Over 3 Years
Tuohinen, S.S. et al. J Am Coll Cardiol CardioOnc. 2021;3(2):277–89.
A bullseye configuration of the left ventricle (LV) and change in for changes in systolic
and early diastolic strain rate. The middle of the image presents the LV apex circled by
apical, mid, and basal segments from middle to the outer layers, respectively. Green
indicates improved function, while yellow and orange show worsening of the function
in 1 or several follow-up visits, respectively. The worsening in diastolic strain rate is
greater than the changes in systolic strain rate. The green area with orange lines
indicate that this segment had both a significant increase (baseline to post-RT) and
decrease (post-RT to 3-year control). IQR ¼ interquartile range.
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283(p ¼ 0.043 for between-group differences). In patients
without a significant change in GLS, the early mitral
inflow velocity declined by 4 (IQR: –3 to 11) cm/s
(p¼ 0.013), and the declaration time of the early mitral
inflow slope was prolonged by 20 (IQR: –14 to 58) ms
(p ¼ 0.007); in contrast, patients with DGLS15 had a
stable early mitral inflow velocity (p ¼ 0.650) and
declaration time of the early mitral inflow slope
(p¼0.008) that was shortened by amedian of –39 (IQR:
–68 to –17) ms. Furthermore, in patients with DGLS15,
the global SRe declined (p¼0.020), the LAVI increased
(p ¼ 0.061), and the tricuspid regurgitation gradient
increased (p ¼ 0.005) by 0.3 (IQR: 0.1 to 0.5) s-1, 4 
10 ml, and 7.1  5.6 mm Hg, respectively. There was a
reduction in SReapex in those without DGLS15
(p ¼ 0.051) with a decline of 0.1 (IQR: –0.1 to 0.4) s-1;
however, the change in patients with DGLS15
(p ¼ 0.017) was worse, with a reduction of 0.4 (IQR: 0.1
to 0.7) s-1.
DISCUSSION
Chest RT is associated with changes in diastolic
function and heart failure with preserved ejection
fraction (2,7). Our study supports these findings, as
SRe changes appeared early and were more consistent
than were changes in SRs. We also found that wors-
ening diastolic function was detectable even in pa-
tients without significant changes in systolic
function, as determined by GLS.
RT-INDUCED FIBROSIS. Biomarker studies, histo-
logic studies, and cardiac positron emission tomog-
raphy have shown that the early-phase RT-induced
cardiac damage is characterized by microvascular
inflammation and oxidative stress (7,12,13). Endo-
thelial damage leads to capillary thrombosis, capillary
vessel rarefication, and myocardial perfusion defects
in the areas within the RT fields (14,15). Once initi-
ated, the process may continue, leading to progres-
sive accumulation of diffuse fibrosis and cell atrophy
(15,16), which may lead to the myocardial thickening
and restrictive diastolic function (7,17,18). In a study
by Saiki et al. (2), 8% of breast cancer patients treated
with RT developed heart failure within 6 years. Heart
failure was predominantly diastolic, and the risk for
heart failure with preserved ejection fraction
increased by 16-fold after RT (2). In another study by
Saiki et al. (7), evidence of RT was associated with
changes in hemodynamics indicating increased LV
stiffness, impaired relaxation, and higher LV end-
diastolic pressure without changes in systolic func-
tion (7). These changes were more pronounced in
patients receiving higher radiation doses, and were
absent in nonradiated subjects.RT-INDUCED CHANGES IN CONVENTIONAL MEASURES
OF DIASTOLIC FUNCTION. The early phase of LV filling
is determined by LV relaxation and LV filling pres-
sures. In conventional echocardiography, the evalu-
ation of diastolic function is a complex task involving
several parameters, by which diastolic function can
be graded as normal or abnormal, according to grades
1 to 3 (11). Studies of post-RT changes using echo-
cardiography have usually focused on changes in
systolic function, and detailed data on multiple dia-
stolic function parameters are lacking (5,9).
In our study, some of the diastolic parameters
worsened during the 3 years of follow-up across the
entire cohort. However, in the majority of the pa-
tients (n ¼ 46, 67.8%) diastolic grade was not
FIGURE 3 Associations Between Apex SRe and Heart Radiation Dose
(A, C, E, G) The whole heart dose; (B, D, F, H) left ventricular dose. From top to bottom, (A, B) mean and (C, D) maximal doses and volumes receiving more than (E, F)
45 Gy and (G, H) 20 Gy radiation doses. FU ¼ follow-up; SRe ¼ early diastolic strain rate.
Continued on the next page
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284worsened. This might be secondary to diastolic grade
being a combination of several measurements, which
are affected by multiple factors.
Individual parameters of diastolic function also
changed over time as the LAVI and tricuspid regur-
gitant gradient increased. In categorizing patients
according to changes in GLS, a more precise pattern
was recognized. Patients with and without DGLS15
displayed different changes in conventional diastolic
parameters. Patients without a DGLS15 showed
reduced mitral inflow E-wave and prolonged decla-
ration times during the 3-year follow-up, indicating a
shift toward relaxation abnormalities that may be
more consistent with grade 1 diastolic dysfunction. In
contrast, patients with DGLS15 had unchanged mitral
inflow E waves but shorter declaration times,
increased LAVIs, and increased tricuspidregurgitation gradients, potentially indicating a shift
toward grade 2 to 3 diastolic dysfunction. These
findings might suggest that these changes are in-
dicators of RT-induced myocardial damage.
EARLY DIASTOLIC SR. Global SRe has been studied
to understand increases in LV filling pressure and as a
potential prognostic marker. In a study by Morris
et al. (19), the normal range of global SRe in healthy
subjects was 1.56  0.28 s-1, and SRedep was associ-
ated with a 5-fold increased risk of heart failure hos-
pitalization. The global SRe has also been validated
with invasive measurements of LV filling pres-
sures (20–22).
Changes in SRe have been previously studied by
Sritharan et al. (3), who showed a significant post-
RT reduction over 6 weeks. In our study, the
decline in global SRe was largely apparent in
FIGURE 3 Continued
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285patients who also had a DGLS15. The number of
patients with SRedep increased from 11 patients at
baseline to 21 immediately after RT (p ¼ 0.013) and
to 17 at 3 years of follow-up (p ¼ 0.051). The fre-
quency of SRedep was highest immediately after RT,
possibly related to the early effects of RT on very
sensitive measures of cardiac function. In multi-
variable analysis, cardiac abnormalities at baseline
were inversely associated with SRedep after RT. It
may be that this association is confounded, and
treatment for pre-existing heart disease had a pro-
tective effect to radiation in the early phase after
RT. The baseline Charlson comorbidity index was
independently associated with SRedep at 3 years. It
is tempting to speculate that a pre-existing micro-
vascular defect that worsens with age and other
comorbidities would make the heart more vulner-
able to RT-induced microvascular damage (2,13). In
keeping with this, comorbidities were associated
with SRedep and SReapex in our study.
The regional changes after RT in SRe were more
evident than changes in global SR. The regionalchanges were concentrated in areas within the RT
fields. According to our data and the results of a cross-
sectional study by Taylor et al. (23), in patients with
left-sided breast cancer, the LV apex and anterior
parts of the heart receive the highest radiation dose
from the contemporary tangential RT fields. In
contrast, in patients with hypertension and cardio-
myopathy, the regional SR decline tends to occur in
basal areas (24,25). The distribution of the regional
changes may help us to understand the underlying
pathologic basis for these changes.
It remains unclear which RT dose-volume metrics
are most strongly associated with abnormalities in
cardiac function—mean heart dose, the overall vol-
ume of the heart in the RT fields, or the maximum
dose? In a review by Niska et al. (26), high doses to
small volumes were associated with worse outcomes
early after RT, while in the long term, the mean heart
dose was associated with increased cardiac mortality.
In our study, DLVmax showed a stronger association
with DSReapex than the mean dose or other radiation
dose-volume metrics.
TABLE 3 Segmental Strain Rates
Baseline (n ¼ 53) After RT (n ¼ 58) 3-Year Follow-Up (n ¼ 60) p Value
Systolic
Basal anterior –1.41 (–1.91 to –0.96) –1.78 (–2.15 to –1.13)* –1.49 (–1.84 to –1.18)† 0.012
Basal anteroseptal –1.29 (–1.78 to –1.05) –1.31 (–1.90 to –1.08) –1.46 (–1.86 to –1.10) 0.581
Basal inferoseptal –1.10 (–1.28 to –0.90) –1.13 (–1.44 to –0.91) –1.08 (–1.22 to –0.87) 0.401
Basal inferior –1.54 (–2.00 to –1.10) –1.47 (–2.46 to –1.11) –1.37 (–1.80 to –1.02) 0.202
Basal inferolateral –1.39 (–1.98 to –1.00) –1.57 (–2.22 to –1.09) –1.98 (–2.50 to –1.22)* 0.029
Basal anterolateral –1.53 (–2.09 to –1.26) –1.74 (–2.28 to –1.39) –1.97 (–2.51 to –1.44)‡ 0.057
Mid anterior –1.17 (–1.62 to –0.88) –1.13 (–1.61 to –0.78) –1.20 (–1.74 to –0.89) 0.967
Mid anteroseptal –1.37 (–1.69 to –1.03) –1.25 (–1.57 to –1.00) –1.30 (–1.53 to –0.96) 0.532
Mid inferoseptal –1.17 (–1.43 to –1.01) –1.23 (–1.40 to –1.00) –1.17 (–1.33 to –0.98) 0.361
Mid inferior –1.22 (–1.48 to –0.95) –1.36 (–1.75 to –1.06) –1.18 (–1.63 to –0.91) 0.133
Mid inferolateral –1.34 (–1.86 to –1.06) –1.18 (–1.54 to –0.93) –1.34 (–2.09 to –1.04)† 0.047
Mid anterolateral –1.43 (–2.00 to –0.99) –1.20 (–1.73 to –0.80)‡ –1.33 (–2.08 to –0.99) 0.076
Apical anterior –0.89 (–1.23 to –0.71) –0.90 (–1.13 to –0.66) –0.84 (–1.04 to –0.65) 0.180
Apical anteroseptal –0.96 (–1.33 to –0.81) –1.02 (–1.24 to –0.72) –0.98 (–1.27 to –0.80) 0.910
Apical inferoseptal –1.23 (–1.45 to –1.10) –1.29 (–1.52 to –1.06) –1.28 (–1.52 to –1.10) 0.957
Apical inferior –1.22 (–1.38 to –1.08) –1.16 (–1.37 to –0.99) –1.04 (–1.32 to –0.86)* 0.017
Apical inferolateral –1.29 (–1.50 to –1.03) –1.18 (–1.36 to –0.97) –1.12 (–1.27 to –0.92) 0.108
Apical anterolateral –0.96 (–1.18 to –0.72) –0.91 (–1.19 to –0.70) –0.82 (–1.00 to –0.68)†‡ 0.041
Apex (4 chamber) –1.06 (–1.23 to –0.84) –1.02 (–1.23 to –0.88) –1.05 (–1.14 to –0.85) 0.441
Apex (3 chamber) –0.98 (–1.30 to –0.86) –0.91 (–1.14 to –0.78) –0.88 (–1.08 to –0.75)* 0.028
Apex (2 chamber) –1.05 (–1.31 to –0.82) –0.98 (–1.23 to –0.82) –0.97 (–1.12 to –0.80) 0.227
Early diastolic
Basal anterior 1.11 (0.62 to 1.64) 1.12 (0.81 to 1.62) 1.09 (0.73 to 1.64) 0.923
Basal anteroseptal 0.92 (0.53 to 1.27) 1.10 (0.66 to 1.55) 0.81 (0.43 to 1.19)§ 0.036
Basal inferoseptal 0.85 (0.58 to 1.18) 0.77 (0.56 to 1.09) 0.80 (0.45 to 1.07) 0.328
Basal inferior 0.94 (0.55 to 1.40) 1.14 (0.72 to 1.55) 1.09 (0.62 to 1.56) 0.407
Basal inferolateral 1.18 (0.73 to 1.51) 1.07 (0.47 to 1.52) 1.01 (0.56 to 1.46) 0.258
Basal anterolateral 1.12 (0.84 to 1.60) 1.15 (0.72 to 1.58) 1.25 (0.64 to 1.68) 0.816
Mid anterior 1.18 (0.80 to 1.89) 1.20 (0.60 to 1.83) 1.25 (0.73 to 1.83) 0.635
Mid anteroseptal 1.29 (1.01 to 1.70) 1.23 (0.69 to 1.98) 0.91 (0.62 to 1.50)†‡ 0.056
Mid inferoseptal 1.16 (0.84 to 1.54) 1.10 (0.92 to 1.40) 1.12(0.89 to 1.47) 0.984
Mid inferior 0.98 (0.69 to 1.50) 0.94 (0.70 to 1.43) 0.97 (0.63 to 1.52) 0.858
Mid inferolateral 0.97 (0.64 to 1.32) 1.01 (0.62 to 1.60) 1.14 (0.56 to 1.64) 0.565
Mid anterolateral 1.08 (0.70 to 1.72) 0.98 (0.58 to 1.57) 1.04 (0.66 to 1.56) 0.329
Apical anterior 1.07 (0.74 to 1.48) 0.82 (0.60 to 1.25)* 0.99 (0.68 to 1.32) 0.032
Apical anteroseptal 1.20 (0.75 to 1.56) 1.02 (0.65 to 1.22)‡ 0.99 (0.72 to 1.24)‡ 0.041
Apical inferoseptal 1.44 (1.00 to 1.97) 1.48 (1.07 to 1.69) 1.28 (0.97 to 1.62)†‡ 0.063
Apical inferior 1.22(0.84 to 1.59) 1.05 (0.80 to 1.41) 0.99 (0.74 to 1.33) 0.377
Apical inferolateral 1.19 (0.90 to 1.64) 1.02 (0.73 to 1.42)‡ 0.97 (0.68 to 1.25)* 0.009
Apical anterolateral 1.01 (0.79 to 1.50) 1.02 (0.72 to 1.51) 0.92 (0.62 to 1.20)† 0.061
Apex (4 chamber) 1.24 (0.93 to 1.66) 1.15 (0.91 to 1.40) 1.00 (0.76 to 1.37)*§ 0.006
Apex (3 chamber) 1.21 (0.85 to 1.44) 0.94 (0.70 to 1.21)* 0.90 (0.69 to 1.29)* 0.008
Apex (2 chamber) 1.21 (0.84 to 1.54) 0.91 (0.65 to 1.30)* 0.93 (0.78 to 1.18)* 0.004
Values are median (interquartile range). Owing to missing primary data, strain analysis could not be performed in 7 patients at the baseline and in 2 patients after radiotherapy
(RT). The p values were derived from mixed model analysis with values <0.05. *p < 0.01 compared with baseline radiotherapy value. †p < 0.05 compared with after
radiotherapy value. ‡p < 0.05 compared with baseline radiotherapy value. §p < 0.01 compared with after radiotherapy value.
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286EARLY SYSTOLIC SR. Changes in SRs appeared later
and were smaller than changes in SRe. However,
similar to the changes in SRe and conventional dia-
stolic function parameters, the changes in global SRs
were more evident in patients with changes in GLS.
As shown in our previous publications, GLS declinedduring follow-up (6,9). GLS is considered to be an
earlier and more sensitive marker of changes in LV
systolic function than LVEF, and a 15% relative
decline is considered to present clinically significant
deterioration (1). In our study, 16 patients experi-
enced a significant DGLS15 during the 3 years of
TABLE 4 Conventional Echocardiography Parameters
Baseline (n ¼ 60) After RT (n ¼ 60) 3-Year Follow-Up (n ¼ 60) p Value
LVEDD, mm 45.1  4.1 44.7  3.9 45.2  4.4 0.308
LVESD, mm 30.3  3.5 30.0  3.6 30.2  3.5 0.766
LV mass, g 152 (137–174) 158 (139–186)* 154 (129–177)†‡ 0.039
LVEF, % 64.6  6.8 64.9  7.3 59.4  6.9†‡ <0.001
GLS, % –18.3  3.1 –17.3  3.2§ –16.8  3.1† 0.003
E, cm/s 72 (64–83) 67 (58–79)* 68 (61–81) 0.136
dt, ms 230 (203–260) 242 (207–271) 246 (203–279) 0.396
a, cm/s 78  20 75  15 75  19 0.150
E/e0 8.9 (7.1–11.1) 8.5 (7.1–10.0) 9.3 (7.1–10.4) 0.237
e0 (septum) 7.4 (5.8–8.2) 7.0 (5.8–8.1) 6.9 (5.8–7.6) 0.119
e0 (lateral) 9.0 (7.3–11.8) 9.4 (7.2–10.6) 9.2 (7.7–10.4) 0.554
LAVI, ml/m2 32.8  8.4 32.3  8.5 34.9  8.7*|| 0.003
TAPSE, mm 24.2  4.0 22.3  4.0† 23.3  4.3 <0.001
TR gradient, mm Hg 21.5 (19.0–25.0) 21.4 (19.5–24.5) 23.5 (19.8–27.0)*|| 0.016
Values are mean  SD or median (interquartile range). *p < 0.05 compared with baseline radiotherapy value. †p < 0.001 compared with baseline radiotherapy value.
‡p < 0.001 compared with after radiotherapy value. §p < 0.01 compared with baseline radiotherapy value. ||p < 0.05 compared with after radiotherapy value.
a ¼ late diastolic mitral inflow velocity; dt ¼ declaration time of the early inflow slope; E ¼ early mitral inflow velocity; e0 ¼ pulsed tissue Doppler early diastolic velocity of
the basal myocardium; E/e0 ¼ ratio of early mitral inflow velocity and pulsed tissue Doppler early diastolic velocity; LAVI ¼ left atrial volume indexed to body surface area;
LVEF ¼ left ventricular ejection fraction, LVESD ¼ left ventricular end-systolic diameter; TAPSE ¼ tricuspid annular plane systolic excursion; TR gradient ¼ tricuspid regur-
gitation maximal gradient; other abbreviations as in Tables 1 and 2.
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287follow-up. However, changes in diastolic function
were also evident in patients without DGLS15, sug-
gesting that changes in diastolic function may appear
in the absence of detectable changes in sys-
tolic function.
STUDY LIMITATIONS. First, our sample size was
small and from a single institution, limiting both our
ability to adjust for multiple confounders and our
power to detect significant associations, as well as the
generalizability of our findings. The clinical adverse
effects usually appear several years or decades after
RT. Hence, longer follow-up time is needed to un-
derstand the clinical implications of these findings.TABLE 5 Changes in Diastolic Function According to GLS Changes at
DGLS <–15% (n ¼ 37)
Baseline 3-Year Follow-Up
Median IQR Median IQR
Global SRe, s-1 1.16 1.02–1.31 1.11 1.01–1.29
Apex SRe, s-1 1.26 0.99–1.39 1.06 0.88–1.28
e0, s-1 8.09 6.75,10.33 8.23 6.93–9.48
E, cm/s 71 64,85 67 61–81
dt, ms 224 194–250 246 225–291
E/e0 8.7 6.8–10.9 8.3 6.8–10.3
LAVI, ml/m2 33 25–38 33 28–39
TR gradient, mm Hg 21 18–25 22 19–24
DGLS>–15% is indicative of worse systolic function. p1 indicates the change in values from
up between the DGLS groups.
DGLS ¼ change in global longitudinal strain during 3-year follow-up; IQR ¼ interquarOur study design also did not include a control group,
making it difficult to exclude age or other factors that
may have influenced the results. Moreover, there is
an important and notable risk of type I error given the
lack of correction for multiple testing, and as such,
our results are hypothesis generating. The main
technique used, SR analysis, is time-consuming.
Before it can be applied to clinical practice, techno-
logical advancements and additional research are
necessary. Furthermore, the overall usability in clin-
ical practice may be lower than in the current study,
as an experienced, echocardiography-focused cardi-
ologist performed all the acquisition and analysis in3 Years
DGLS >–15% (n ¼ 16)
p2 Valuep1 Value
Baseline 3-Year Follow-Up
p1 ValueMedian IQR Median IQR
0.318 1.14 1.06–1.42 1.10 0.83–1.29 0.020 0.043
0.051 1.15 1.00–1.55 0.97 0.83–1.29 0.017 0.068
0.587 8.06 6.28–8.94 8.02 5.68–8.69 0.609 0.848
0.013 66 60–78 69 62–81 0.650 0.222
0.007 256 208–288 222 169–254 0.008 <0.001
0.118 9.2 6.7–11.5 8.9 8.1–9.9 0.394 0.186
0.323 36 30–40 39 31–42 0.061 0.084
0.379 22 21–27 27 26–32 0.005 <0.001
baseline to the 3-year follow-up. p2 indicates the difference in the changes during the 3-year follow-
tile range; SRe ¼ early diastolic strain rate; other abbreviations as in Table 4.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In
early-stage left-sided breast cancer patients treated
with radiation therapy, changes in sensitive measures
of LV diastolic function and early diastolic SR were
observed, particularly in areas receiving high radiation
dose.
TRANSLATIONAL OUTLOOK: Additional studies
are needed to further define the changes in diastolic
function that occur with radiation therapy and deter-
mine the relationship between changes in LV diastolic
SR and adverse clinical outcomes.
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288the current study, and this resource might not be
available in daily clinical practice.
CONCLUSIONS
Changes in diastolic function were detected early af-
ter RT and during 3 years of follow-up. These changes
suggest a shift toward worsened relaxation patterns
in breast cancer patients treated with RT. Regional
SRe changes in RT-affected areas were detected in
those with and without changes in systolic function,
although they were more pronounced in those with a
significant change in GLS.
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